Viewing Study NCT04541251


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-02-24 @ 10:20 PM
Study NCT ID: NCT04541251
Status: UNKNOWN
Last Update Posted: 2021-06-23
First Post: 2020-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module